Fig. 1: Enhanced chemotherapy response with hyperglycemia in patients with stage IV PDAC.
From: Increased glucose availability sensitizes pancreatic cancer to chemotherapy
Nelson-Aalen cumulative hazard curves of patients with metastatic PDAC, stratified by glycemic status among patients who received ≥ 2 cycles of chemotherapy (a) and those who did not receive any treatment (b). Patients’ data are provided in the Source Data file.
